Tag: antiviral prophylaxis
HBV Reactivation: How Biologics and Chemotherapy Trigger Liver Danger - And How to Prevent It
HBV reactivation can strike silently during chemotherapy or biologic therapy, causing liver failure. Learn who's at risk, which drugs trigger it, and how simple screening and antiviral prophylaxis can save lives.
view morerecent posts
Find the FDA's official list of authorized generics-drugs made by brand companies but sold without the brand name. Learn where to access it, how to interpret it, and why it's not always easy to buy these lower-cost options.
Published ON: 1 DecSwitching from an originator biologic to a biosimilar is safe for most patients with stable autoimmune conditions. Learn what really happens during the switch, why some people stop treatment, and how to make the transition work for you.
Published ON: 17 DecChronic Alcohol Use Disorder affects millions and carries serious health risks-from liver damage to cancer and brain changes. Effective treatments exist, including medications, therapy, and support groups. Recovery is possible with the right help.
Published ON: 1 DecLithium carbonate generics require strict serum level monitoring due to their narrow therapeutic index. Learn how brand switches, dosing, age, and kidney function affect safety and effectiveness in bipolar disorder treatment.
Published ON: 12 DecPrescriber override lets doctors require brand-name drugs instead of generics when safety is at risk. Learn how DAW-1 codes work, state-by-state rules, and when overrides are necessary-or dangerous.
Published ON: 15 Dec